News | August 09, 2011

Acist Contrast Delivery System Facilitates Diagnosis of 10 Millionth Patient

August 9, 2011 — Acist Medical Systems Inc., a Bracco Group company and provider of advanced contrast injection system technology for cardiovascular angiography, announced that its’ contrast delivery system has been used to help diagnose and treat 10 million patients.

The Acist system is an all-in-one, variable-flow technology giving physicians control over the full range of injection volumes, from small coronary vessels to large ventricular vessels and peripheral vasculature. The system’s widespread adoption in prestigious teaching institutions as well as mainstream community-based hospitals has demonstrated benefits in reducing costs and complexity and in enhancing patient care.

“The Acist contrast delivery system was developed to help doctors perform angiography more efficiently and, in turn, facilitate timely and appropriate treatment,” said Robert Wilson, M.D., inventor of the Acist system and professor of interventional cardiology at the University of Minnesota. “The system shortens procedures, decreases the amount of dye injected into patients and reduces radiation exposure for health care professionals and patients.”

During an angiogram, iodine-based X-ray contrast dye is injected into the heart arteries through a catheter in a patient’s leg or arm. Cardiologists rely on angiographic imaging to see inside the heart’s arteries, diagnose heart disease and determine which patients need surgery or angioplasty. 

The system replaces traditional injection methods that rely on manual manipulation of a hand injection syringe and stopcocks for small coronary vessels. Large vessels typically require a fixed-rate power injector, as well as manual tracking of contrast use.

Air column sensors automatically stop the procedure when air is detected, helping prevent a potentially serious complication for the patient. 

The unique hand controller facilitates precise administration of contrast for more consistent imaging with lower contrast amounts, reducing radiation exposure. It also allows clinicians to step back from the radiation source during imaging to reduce radiation exposure, and deliver contrast without the stress of manually injecting throughout the heart’s vessels. This reduces hand fatigue and the potential for carpal tunnel syndrome.

For more information: www.acist.com

Related Content

OptiStar Elite injector
Feature | Contrast Media Injectors | March 07, 2018 | Grand View Research Inc.
The global contrast media injectors market is expected to reach $1.4 billion by 2025, growing at a compound annual...
TriHealth in Cincinnati

TriHealth in Cincinnati.

Sponsored Content | Case Study | Contrast Media Injectors | March 06, 2018
The continuing search for advantages to improve workflow has radiology departments constantly searching for new...
Guerbet Presents Contrast&Care Injection Management Solution at ECR 2018
News | Contrast Media | February 28, 2018
February 28, 2018 — Guerbet will present its new Contrast&Care application, as well as other...
Guerbet to Participate in French Interventional Radiology Conference
News | Contrast Media | October 10, 2017
Guerbet announced it will be taking part in the 65th edition of the Journées Francophones de Radiologie (JFR) that will...
ACR Offers Revised Contrast Media in Imaging Manual
News | Contrast Media | July 17, 2017
The American College of Radiology (ACR) recently revised its authoritative guide for the safe and effective use of...
Sponsored Content | Case Study | Contrast Media Injectors | April 13, 2017
The volume of computed tomography (CT) imaging exams continues to grow in the United States,[2] adding pressure to...
contrast media
Feature | Contrast Media Injectors | March 02, 2017 | By Jeff Zagoudis
With medical imaging use on the rise, contrast media use is expected to grow as well, according to a May 2016 report...
contrast media
News | Contrast Media | December 09, 2016
At the 2016 Annual Meeting of the Radiological Society of North America (RSNA 2016), Bracco Diagnostics Inc. showcased...
GlobalData, contrast media injectors market,
News | Contrast Media Injectors | May 03, 2016
The global market for contrast media injectors is set to increase from $830 million in 2015 to almost $1.8 billion by...
CTA, CT, contrast media injector, contrast injector, EmpowerCTA

Bracco's new EmpowerCTA+, designed for cardiac CT angiography exams.

Feature | Contrast Media Injectors | April 29, 2016 | Jeff Zagoudis
The biggest trend in contrast media injector technology today is one seen throughout all of healthcare — doing more...
Overlay Init